Related Experiment Video
Updated: Nov 8, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Health economic evaluations of medical tests: Translating laboratory information into value - A case study example
Paul Jülicher1, Maurice O'Kane2,3, Christopher P Price4
1Health Economics and Outcomes Research, Medical Affairs, Abbott Laboratories, Wiesbaden, Germany.
This article explains how health economic models can help assess the value of medical tests. It provides a step-by-step framework for laboratory professionals to evaluate test impact. The process includes mapping clinical pathways, identifying stakeholders, and using decision analytic models. Data collection and model validation are key steps. Sensitivity analysis ensures results are reliable. The final step translates findings into value metrics. These metrics help stakeholders make informed decisions. The study suggests that this approach can help laboratories demonstrate test value.
Area of Science:
- Health economics in clinical diagnostics
- Laboratory medicine value assessment
- Decision analytic modeling in healthcare
Background:
Healthcare systems increasingly emphasize cost-effectiveness. Laboratory services are no exception. Prior research has shown that providers and funders seek value across all services. However, no prior work had resolved how to translate laboratory data into economic terms. Existing knowledge includes the need for economic modeling in healthcare. Yet, uncertainty remains about how to apply these models in laboratory settings. This gap motivated the exploration of health economic tools. That uncertainty drove the development of a framework for laboratory professionals. No prior work had resolved the specific steps for such evaluations. This paper introduces a structured approach to assess test value.
Purpose Of The Study:
The goal is to guide laboratory professionals in evaluating test value. This involves using health economic models to assess test impact. The specific problem is how to translate test data into economic terms. The motivation is to help laboratories secure resources. The study focuses on decision analytic models. These models compare outcomes with and without new tests. The aim is to provide a step-by-step framework. This approach helps stakeholders understand test value.
Main Methods:
The study uses a decision analytic modeling framework. It begins with mapping the clinical pathway for the test. Next, it identifies stakeholders and their needs. The process includes selecting a suitable analytical model. Data collection follows, focusing on test outcomes. Model validity is checked through standard procedures. Sensitivity analysis tests outcome robustness. The final step translates findings into value metrics. This approach ensures a structured evaluation of test impact.
Main Results:
The framework includes mapping clinical pathways and identifying stakeholders. Data collection focuses on test outcomes and pathways. Model validity is confirmed through standard checks. Sensitivity analysis ensures outcome robustness. The final step translates findings into value metrics. These metrics inform stakeholder decisions. The study shows how to apply decision analytic models. It provides a clear process for economic test evaluation.
Conclusions:
The authors propose that decision analytic models can assess test value. They suggest that mapping pathways is essential. Identifying stakeholders helps tailor evaluations. Validating models ensures accuracy. Sensitivity analysis confirms result reliability. Translating findings into value metrics is crucial. The study implies that this framework can guide laboratory professionals. It may help laboratories demonstrate test value to stakeholders.
Frequently Asked Questions
The main outcome is translating test data into value metrics that inform stakeholder decisions.
Stakeholder identification ensures the evaluation addresses relevant needs and goals.
Sensitivity analysis tests outcome robustness and confirms model validity.
It compares outcomes with and without the new test using decision analytic models.
The final step is translating findings into value metrics for stakeholders.
The authors propose that these models can help assess the economic value of medical tests.
More Related Videos
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Hazard Ratio
For example, in a clinical trial...
Serum Laboratory Studies, Stool Test, Breath Test

